Listed

Mettler Toledo International Inc/: Form 10-Q for the period ended Mar 31, 2016

Filed with the SEC on May 6, 2016 and accepted by EDGAR at May 6, 2016, 09:32 ET.

Share

Management's discussion and analysis

As filed, 23,575 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.

General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the full year ending December 31, 2016.

Changes in local currencies exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.

Results of Operations – Consolidated

The following tables set forth items from our interim consolidated statements of operations and comprehensive income for the three month periods ended March 31, 2016 and 2015 (amounts in thousands).

Three months ended March 31, 2016 (unaudited)% 2015 (unaudited)%
Net sales $539,674 100.0 $535,701 100.0
Cost of sales 239,767 44.4 236,896 44.2
Gross profit 299,907 55.6 298,805 55.8
Research and development 28,973 5.4 28,461 5.3
Selling, general and administrative 168,921 31.3 173,038 32.3
Amortization 8,424 1.6 7,528 1.4
Interest expense 6,580 1.2 6,725 1.3
Restructuring charges 880 0.2 907 0.2
Other charges (income), net (284) (0.1) (817) (0.2)
Earnings before taxes 86,413 16.0 82,963 15.5
Provision for taxes 20,739 3.8 19,912 3.7
Net earnings $65,674 12.2 $63,051 11.8

Net sales

Net sales were $539.7 million for the three months ended March 31, 2016, compared to $535.7 million for the corresponding period in 2015. This represents an increase in U.S. dollars of 1%. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 4% for the three months ended March 31, 2016. While market conditions continue to be strong in the United States, we remain cautious about our sales growth outlook as global market conditions remain uncertain, including in emerging markets.

Net sales by geographic destination for the three months ended March 31, 2016, in U.S. dollars increased 5% in the Americas, and decreased 2% in Europe and 1% in Asia/Rest of World. In local currencies, our net sales by geographic destination increased 6% in the Americas, 4% in Asia/Rest of World, and were flat in Europe. A discussion of sales by operating segment is included below.

As described in Note 17 to our consolidated financial statements for the year ended December 31, 2015, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products were flat in U.S. dollars and increased 3% in local currency for the three months ended March 31, 2016 compared to the prior period. Service revenue (including spare parts) increased 3% in U.S. dollars and 6% in local currency during the three months ended March 31, 2016 compared to the corresponding period in 2015.

Net sales of our laboratory-related products, which represented approximately 49% of our total net sales for the three months ended March 31, 2016, increased 2% in U.S. dollars and 5% in local currencies during the three months ended March 31, 2016. The local currency increase included growth in most product categories, including strong growth in pipettes.

Net sales of our industrial-related products, which represented approximately 42% of our total net sales for the three months ended March 31, 2016, decreased 1% in U.S. dollars and 2% in local currencies during the three months ended March 31, 2016. The local currency increase in net sales of our industrial-related products includes solid growth in product inspection offset by a modest volume decline in core industrial products during the three months ended March 31, 2016.

Net sales in our food retailing markets, which represented approximately 9% of our total net sales for the three months ended March 31, 2016, increased 2% in U.S. dollars and increased 5% in local currencies during the three months ended March 31, 2016, with strong volume growth in the Americas and Asia/Rest of World, offset in part by reduced sales volume in Europe.

Gross profit

Gross profit as a percentage of net sales was 55.6% for the three months ended March 31, 2016 compared to 55.8% for the corresponding period in 2015.

Gross profit as a percentage of net sales for products was 59.9% and 60.1% for the three month periods ended March 31, 2016 and 2015.

Gross profit as a percentage of net sales for services (including spare parts) was 41.5% for the three months ended March 31, 2016 compared to 41.2% for the corresponding period in 2015.

The decrease in gross profit as a percentage of net sales for the three months ended March 31, 2016 includes unfavorable business mix and investments in our field service organization, partly offset by favorable price realization and reduced material costs.

Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales were 5.4% for the three months ended March 31, 2016 and 2015. Research and development expenses increased 1% in U.S. dollars and 5% in local currencies, during the three months ended March 31, 2016 compared to the corresponding period in 2015.

Selling, general and administrative expenses as a percentage of net sales were 31.3% for the three months ended March 31, 2016 compared to 32.3% in the corresponding period during 2015. Selling, general and administrative expenses decreased 2% in U.S. dollars and increased 1% in local currencies, during the three months ended March 31, 2016 compared to the corresponding period in 2015. The local currency increase includes investments in our field sales organization and higher cash incentive expense, offset in part by benefits from our cost savings initiatives.

Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $8.4 million for the three months ended March 31, 2016 and $7.5 million for the corresponding period in 2015.

Interest expense was $6.6 million for the three months ended March 31, 2016 and $6.7 million for the corresponding period in 2015.

Other charges (income), net consists primarily of (gains) losses from foreign currency transactions, interest income and other items.

The provision for taxes is based upon using our projected annual effective tax rate of 24% for the three month periods ended March 31, 2016 and 2015. Our consolidated income tax rate is lower than the U.S. statutory rate primarily because of benefits from lower-taxed non-U.S. operations. The most significant of these lower-taxed operations are in Switzerland and China.

Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 17 to our consolidated financial statements for the year ended December 31, 2015.

U.S. Operations (amounts in thousands)

Three months ended March 31,
2016 2015%
Total net sales $207,565 $197,199 5%
Net sales to external customers $187,935 $178,907 5%
Segment profit $29,155 $24,329 20%

Total net sales and net sales to external customers both increased 5% for the three months ended March 31, 2016 compared with the corresponding period in 2015. The increase in total net sales and net sales to external customers for the three months ended March 31, 2016 reflects strong growth in most product categories with particularly strong volume growth in pipettes, food retailing, and laboratory balances.

Segment profit increased $4.8 million for the three months ended March 31, 2016 compared to the corresponding period in 2015 primarily due to increased net sales and benefits from our margin expansion initiatives, offset in part by increased sales and service investments.

Swiss Operations (amounts in thousands)

Three months ended March 31, 2016 2015 %1)
Total net sales $147,275 $148,910 (1)%
Net sales to external customers $26,965 $30,888 (13)%
Segment profit $35,822 $35,592 1%

1) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 1% in U.S. dollars and increased 3% in local currency for the three months ended March 31, 2016 compared to the corresponding period in 2015. Net sales to external customers decreased 13% in U.S. dollars and 10% in local currency during the three months ended March 31, 2016 compared to the corresponding period in 2015. The decrease in local currency net sales to external customers for the three month period ended March 31, 2016 primarily related to soft market conditions.

Segment profit increased $0.2 million for the three month period ended March 31, 2016 compared to the corresponding period in 2015. Segment profit during the three months ended March 31, 2016 includes the impact of increased inter-segment local currency sales, benefits from our cost savings programs, and reduced material costs, offset in part by higher currency hedging gains in the prior year.

Western European Operations (amounts in thousands)

Three months ended March 31, 2016 2015 %1)
Total net sales $176,198 $182,945 (4)%
Net sales to external customers $137,651 $140,918 (2)%
Segment profit $20,190 $20,341 (1)%

1) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales decreased 4% in U.S. dollars and 1% in local currencies during the three month period ended March 31, 2016 compared to the corresponding period in 2015. Net sales to external customers decreased 2% in U.S. dollars and were flat in local currencies during the three month period ended March 31, 2016 compared to the corresponding period in 2015. Local currency net sales to external customers for the three months ended March 31, 2016 increased in laboratory-related products offset by volume declines in industrial-related products and food retailing.

Segment profit decreased $0.2 million for the three month period ended March 31, 2016 compared to the corresponding period in 2015. The decrease in segment profit includes the impact of decreased net sales and increased sales and service investments, offset in part by the benefits from our margin expansion initiatives and cost savings initiatives.

Chinese Operations (amounts in thousands)

Three months ended March 31, 2016 2015 %1)
Total net sales $130,874 $129,954 1%
Net sales to external customers $84,947 $86,449 (2)%
Segment profit $36,626 $34,558 6%

1) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales increased 1% in U.S. dollars and 7% in local currency during the three months ended March 31, 2016 compared to the corresponding period in 2015. Net sales to external customers decreased 2% in U.S. dollars and increased 4% in local currency during the three months ended March 31, 2016 as compared to the corresponding period in 2015. The increase in local currency net sales to external customers during the three months ended March 31, 2016 reflects growth in most product categories. Chinese market conditions remain uncertain and the outlook is unclear.

Segment profit increased $2.1 million for the three month period ended March 31, 2016 compared to the corresponding period in 2015. The increase in segment profit for the three month period ended March 31, 2016 includes increased local currency net sales and benefits from our cost savings initiatives.

Other (amounts in thousands)

Three months ended March 31, 2016 2015 %1)
Total net sales $103,530 $99,896 4%
Net sales to external customers $102,176 $98,539 4%
Segment profit $11,094 $9,103 22%

1) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales and net sales to external customers increased 4% in U.S. dollars and increased 10% in local currencies during the three month period ended March 31, 2016 compared to the corresponding period in 2015. The local currency increase in net sales to external customers includes particularly strong volume growth and increased price realization in several countries. These results were offset in part by net sales declines in Russia and Brazil.

Segment profit increased $2.0 million for the three months ended March 31, 2016 compared to the corresponding period in 2015. The increase in segment profit is primarily due to increased net sales, offset in part by unfavorable currency of approximately $1.0 million and increased sales and service investments.

Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $35.7 million during the three months ended March 31, 2016, compared to $58.6 million in the corresponding period in 2015. The decrease in 2016 includes a higher working capital outflow of $19.3 million versus the prior year comparable period primarily due to changes in accounts receivables of $9.6 million and accounts payables of $8.0 million that are primarily related to timing.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $14.3 million for the three months ended March 31, 2016 compared to $18.5 million in the corresponding period in 2015.

We plan to repatriate earnings from China, Switzerland, Germany, the United Kingdom and certain other countries in future years and expect the only additional cost associated with the repatriation of such earnings outside the United States will be any applicable withholding taxes. All other undistributed earnings are considered to be permanently reinvested. As of March 31, 2016, we have an immaterial amount of cash and cash equivalents outside the United States where undistributed earnings are considered permanently reinvested. Accordingly, we believe the tax impact associated with repatriating our undistributed foreign earnings will not have a material effect on our liquidity.

Senior Notes and Credit Facility Agreement

Our debt consisted of the following at March 31, 2016:

March 31, 2016 U.S. Dollar Other Principal Trading Currencies Total
$50 million Senior Notes, interest 3.67%, due December 17, 2022 $50,000 $— $50,000
$50 million Senior Notes, interest 4.10%, due September 19, 2023 50,000 — 50,000
$125 million Senior Notes, interest 3.84%, due September 19, 2024 125,000 — 125,000
$125 million Senior Notes, interest 4.24%, due June 25, 2025 125,000 — 125,000
Euro 125 million Senior Notes, interest 1.47%, due June 17, 2030 — 140,150 140,150
Debt issuance costs, net (1,388) (406) (1,794)
Total Senior Notes 348,612 139,744 488,356
$800 million Credit Agreement, interest at LIBOR plus 87.5 basis points 176,500 17,016 193,516
Other local arrangements — 17,381 17,381
Total debt 525,112 174,141 699,253
Less: current portion — (17,381) (17,381)
Total long-term debt $525,112 $156,760 $681,872

As of March 31, 2016, approximately $602.0 million was available under our Credit Agreement. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.

We currently believe that cash flow from operating activities, together with liquidity available under our credit facility and local working capital facilities, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for at least the foreseeable future.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. In 2016, we consummated acquisitions totaling $4.3 million, which includes additional cash consideration of $0.5 million. Goodwill recorded in connection with the acquisitions totaled $2.0 million. We also recorded $1.2 million of identified intangibles primarily pertaining to customer relationships in connection with the acquisitions, which will be amortized on a straight-line basis over 10 years.

Share Repurchase Program

The Company has a share repurchase program of which there was $1.4 billion of common shares remaining to be repurchased under the program as of March 31, 2016. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and existing cash balances. Repurchases will be made through open market transactions, and the amount and timing of repurchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors.

We have purchased 25.0 million shares since the inception of the program through March 31, 2016. During the three months ended March 31, 2016 and 2015, we spent $125.0 million and $123.7 million on the repurchase of 390,337 shares and 400,845 shares at an average price per share of $320.22 and $308.69, respectively. We reissued 59,321 shares and 125,398 shares held in treasury for the exercise of stock options and restricted stock units during the three months ended March 31, 2016 and 2015, respectively.

Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down.

We entered into foreign currency forward contracts that reduce our exposure from the Swiss franc strengthening against the euro through 2016. The notional amount and average forward rate of our foreign currency forward contracts at March 31, 2016 is Euro 51.6 million and 1.19 for contracts that mature in 2016. Absent these forward currency forward contracts, we estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.2 million to $1.4 million annually. We also estimate a 1% strengthening of the Swiss franc against the U.S. dollar would reduce our earnings before tax by approximately $0.4 million to $0.6 million annually in addition to the previously mentioned strengthening of the Swiss franc against the euro impact.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $0.3 million to $0.5 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at March 31, 2016, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $19.4 million in the reported U.S. dollar value of our debt.

Forward-Looking Statements Disclaimer

You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue”.

We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position , capital expenditures, cash flow, tax-related matters, compliance with laws, and effects of acquisitions.

Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2015 Annual Report on Form 10-K.

Market risk

As filed, 174 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of March 31, 2016, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

Controls and procedures

As filed, 772 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including the Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 201 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For the three months ended March 31, 2016 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-01-01 to 2016-03-31$539.7mus-gaap:Revenues
Cost of revenue3 months2016-01-01 to 2016-03-31$165.9mus-gaap:CostOfGoodsSold
Gross profit3 months2016-01-01 to 2016-03-31$299.9mus-gaap:GrossProfit
Research and development3 months2016-01-01 to 2016-03-31$29.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-01-01 to 2016-03-31$168.9mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2016-01-01 to 2016-03-31$6.6mus-gaap:InterestExpense
Income tax3 months2016-01-01 to 2016-03-31$20.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-01-01 to 2016-03-31$65.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-01-01 to 2016-03-31$2.40us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-01-01 to 2016-03-31$2.44us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-01-01 to 2016-03-3127,421,019 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2016-01-01 to 2016-03-31$35.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2016-01-01 to 2016-03-31$14.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2016-01-01 to 2016-03-31$125.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-03-31$110.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-03-31$866.7mus-gaap:AssetsCurrent
Total assetsAt period end2016-03-31$2.04bnus-gaap:Assets
Current liabilitiesAt period end2016-03-31$544.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-03-31$1.49bnus-gaap:Liabilities
Long-term debtAt period end2016-03-31$681.9mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2016-03-31$543.3mus-gaap:StockholdersEquity
Shares outstandingAt period end2016-03-3126,759,102 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001037646-16-000051. Last ingested by Listed: Nov 13, 2026, 02:43 ET. Listed shows no prices and gives no investment advice.